Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.64 USD | -2.15% | -2.64% | -37.10% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.10% | 839M | |
-1.69% | 102B | |
+2.22% | 96.09B | |
+2.13% | 22.28B | |
-16.60% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.79% | 16.09B | |
+5.15% | 13.83B | |
+33.80% | 11.97B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Scotiabank Cuts Price Target on Sage Therapeutics to $19 From $34, Maintains Sector Outperform Rating